Clinical trials
Phase 2/3 Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Forest Laboratories | 2 |
| AN2 Therapeutics, Inc | 1 |
| Columbia University | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| NeuroBo Pharmaceuticals Inc. | 1 |
| Stanford University | 1 |
| University of Miami | 1 |
| University of Washington | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infections | 10 |
| Surgical Wound Infection | 2 |
| Wounds and Injuries | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Agammaglobulinemia | 1 |
| Bites and Stings | 1 |
| COVID-19 | 1 |
| Community-Acquired Pneumonia | 1 |
| Cross Infection | 1 |
| Esthesioneuroblastoma, Olfactory | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.